The University of Chicago Header Logo

Connection

Samuel Hellman to Neoplasm Metastasis

Back to Details
This is a "connection" page, showing publications Samuel Hellman has written about Neoplasm Metastasis.
Samuel Hellman
Connection Strength
1.080
Neoplasm Metastasis
  1. Individual characterisation of the metastatic capacity of human breast carcinoma. Eur J Cancer. 2000 Aug; 36(13 Spec No):1631-9.
    View in: PubMed
    Score: 0.132
  2. Breast cancer metastatic phenotype as predicted by histologic tumor markers. Cancer J Sci Am. 1997 Jul-Aug; 3(4):224-9.
    View in: PubMed
    Score: 0.106
  3. Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones. J Vis Exp. 2016 11 30; (117).
    View in: PubMed
    Score: 0.102
  4. Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs. Clin Exp Metastasis. 2014 Aug; 31(6):735-48.
    View in: PubMed
    Score: 0.086
  5. Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy. J Clin Oncol. 2013 Apr 10; 31(11):1384-90.
    View in: PubMed
    Score: 0.079
  6. MicroRNA expression characterizes oligometastasis(es). PLoS One. 2011; 6(12):e28650.
    View in: PubMed
    Score: 0.072
  7. Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer. 2012 Jun 01; 118(11):2962-70.
    View in: PubMed
    Score: 0.072
  8. Oligometastases revisited. Nat Rev Clin Oncol. 2011 06; 8(6):378-82.
    View in: PubMed
    Score: 0.069
  9. An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease. Clin Cancer Res. 2008 Aug 15; 14(16):5255-9.
    View in: PubMed
    Score: 0.058
  10. Premise, promise, paradigm and prophesy. Nat Clin Pract Oncol. 2005 Jul; 2(7):325.
    View in: PubMed
    Score: 0.046
  11. Importance of local control in an era of systemic therapy. Nat Clin Pract Oncol. 2005 Feb; 2(2):60-1.
    View in: PubMed
    Score: 0.045
  12. Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment. Int J Oncol. 2004 Dec; 25(6):1677-83.
    View in: PubMed
    Score: 0.045
  13. Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol. 2000 Feb; 18(3):591-9.
    View in: PubMed
    Score: 0.032
  14. Aging, progression, and phenotype in breast cancer. J Clin Oncol. 1998 Aug; 16(8):2686-92.
    View in: PubMed
    Score: 0.029
  15. Darwin's clinical relevance. Cancer. 1997 Jun 15; 79(12):2275-81.
    View in: PubMed
    Score: 0.027
  16. Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes. J Clin Oncol. 1996 Dec; 14(12):3105-11.
    View in: PubMed
    Score: 0.026
  17. 14q32-encoded microRNAs mediate an oligometastatic phenotype. Oncotarget. 2015 Feb 28; 6(6):3540-52.
    View in: PubMed
    Score: 0.023
  18. Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol. 1994 Oct; 12(10):2229-34.
    View in: PubMed
    Score: 0.022
  19. Expedition Inspiration Fund for Breast Cancer Research Meeting 2003. Breast Cancer Res Treat. 2003 Jul; 80(2):139-44.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.